scholarly article | Q13442814 |
P50 | author | Brendon A. Parsons | Q40086293 |
P2093 | author name string | Robert E Synovec | |
Sandra E Juul | |||
Luke C Marney | |||
Ali Shojaie | |||
Ronald J McPherson | |||
Sahar Z Zangeneh | |||
Pattaraporn T Chun | |||
P2860 | cites work | Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis | Q46316924 |
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis | Q46330877 | ||
Effect of GABA on oxidative stress in the skeletal muscles and plasma free amino acids in mice fed high-fat diet | Q46571018 | ||
Urinary metabolomics in newborns and infants | Q46573144 | ||
Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy | Q48162993 | ||
Interrater reliability of a modified Ashworth scale of muscle spasticity | Q69735143 | ||
Is plasma GABA of peripheral origin? | Q69900783 | ||
Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data | Q24650759 | ||
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology | Q26829452 | ||
Global, regional, and national causes of child mortality in 2008: a systematic analysis | Q28282386 | ||
Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs | Q28473135 | ||
Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3 | Q28564152 | ||
Parallel factor analysis (PARAFAC) of target analytes in GC x GC-TOFMS data: automated selection of a model with an appropriate number of factors | Q31100457 | ||
Identification and evaluation of cycling yeast metabolites in two-dimensional comprehensive gas chromatography-time-of-flight-mass spectrometry data | Q31136222 | ||
Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes | Q33612373 | ||
The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders | Q34032586 | ||
The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions | Q34278218 | ||
Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices | Q34566799 | ||
Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model | Q34724200 | ||
Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. | Q35268407 | ||
Perinatal asphyxia in a nonhuman primate model | Q35576374 | ||
Time-dependent profiling of metabolites from Snf1 mutant and wild type yeast cells | Q36299761 | ||
Metabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkey | Q36614882 | ||
Erythropoietin as a neuroprotectant for neonatal brain injury: animal models | Q36624171 | ||
The perinatal transition of the circulating metabolome in a nonhuman primate | Q36744629 | ||
Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells | Q36866923 | ||
1H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries | Q37072704 | ||
A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. | Q37351232 | ||
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia | Q37416401 | ||
Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis | Q37982048 | ||
Clinical application of metabolomics in neonatology. | Q37984553 | ||
Molecular mechanisms of neonatal brain injury | Q37987945 | ||
Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity? | Q38151299 | ||
New diagnostic possibilities in systemic neonatal infections: metabolomics | Q38202767 | ||
Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition | Q38833154 | ||
G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. | Q39052873 | ||
Identifying hypoxia in a newborn piglet model using urinary NMR metabolomic profiling | Q41332782 | ||
Correlation Between Hepatocyte Growth Factor (HGF) and Gamma-Aminobutyric Acid (GABA) Plasma Levels in Autistic Children | Q41547667 | ||
Metabolomics network characterization of resuscitation after normocapnic hypoxia in a newborn piglet model supports the hypothesis that room air is better | Q42076218 | ||
Metabolic adaptation and neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia | Q42219273 | ||
A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome | Q42875477 | ||
GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients. | Q43287368 | ||
P433 | issue | 2 | |
P921 | main subject | hypoxia | Q105688 |
neonatal hypoxic-ischemic encephalopathy | Q5832339 | ||
P304 | page(s) | 161-171 | |
P577 | publication date | 2015-02-27 | |
P1433 | published in | Developmental Neuroscience | Q15763713 |
P1476 | title | Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model | |
P478 | volume | 37 |
Q54969494 | A longitudinal 1H-NMR metabolomics analysis of urine from newborns with hypoxic-ischemic encephalopathy undergoing hypothermia therapy. Clinical and medical legal insights. |
Q91130573 | Advances in the application of comprehensive two-dimensional gas chromatography in metabolomics |
Q47854098 | Blood biomarkers for evaluation of perinatal encephalopathy: state of the art. |
Q55283282 | Cerebral Lactate Concentration in Neonatal Hypoxic-Ischemic Encephalopathy: In Relation to Time, Characteristic of Injury, and Serum Lactate Concentration. |
Q90369673 | Current and Emerging Therapies in the Management of Hypoxic Ischemic Encephalopathy in Neonates |
Q36520524 | Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia |
Q47168684 | Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse. |
Q46246920 | Krebs cycle metabolites and preferential succinate oxidation following neonatal hypoxic-ischemic brain injury in mice |
Q28385013 | Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns |
Q104471876 | Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains |
Q42361461 | Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question? |
Q64947757 | Understanding neonatal hypoxic-ischemic encephalopathy with metabolomics. |
Search more.